THIS NEW HOPE FOR BODY CONTROL ?

Experts are rapidly examining retatrutide, a promising medication developed by Eli Lilly, as a significant step in weight management. Unlike many previous approaches, retatrutide is a double -action receptor targeting both GLP-1 and GIP, hormones that influence appetite and blood glucose control